August 8, 2011
Carrot Medical Positioned for Third Straight Year of Triple Digit Growth
BOSTON, Aug. 8, 2011 /PRNewswire/ -- Carrot Medical, a leading manufacturer of integrated medical imaging display and communication systems, has announced results for Q2 2011. During the year, Carrot Medical achieved significant growth in sales and an expansion of sales channels.
Concluding the first half of 2011 with record second quarter sales, Carrot surpassed its revenue mark for the full year in FY 2010. The company is now well positioned for the third straight year of triple digit growth. Since inception, Carrot has received orders for more than 50( )of its C-View systems, a premium class medical imaging and data integration solution.
"Hospitals are continuing to expand and modernize their cardiovascular programs, adding new technology to the procedure suite. Carrot Medical's vision, since our inception in 2008, has been to integrate this technology, creating a more efficient clinical environment. We are continuing to take advantage of the market demand we created when we launched our C-View system at the RSNA in November 2008," said Ward Sparacio, CEO of Carrot Medical. "Our pipeline and opportunity portfolio has grown by more than 40 percent in the past 6 months alone."
Sparacio also points to Carrot Medical's continued focus on measuring customer satisfaction, using a Net Promoter Scoring methodology. A Net Promoter Score measures how likely it is a customer would recommend a company to a friend or colleague. Carrot has achieved a Net Promoter Score of 88% in the past year on post-installation surveys, which places it among the most esteemed companies.
Carrot Medical is the manufacturer of C-View, an information technology solution that integrates medical images and other visual data onto a single, ultra-high-definition display. Carrot Medical also offers, C-Com, a communication system that allows greater collaboration among clinical team members, while reducing noise and distraction during procedures. Both systems have been purchased by leading healthcare institutions for use within cardiovascular interventional suites.
SOURCE Carrot Medical